Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

TVTX FY 2011 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12,825

Net Income

-$14,825

EPS (Diluted)

$-0.14

Cash Flow

Operating Cash Flow

-$49

Free Cash Flow

-$49

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3,909

Total Liabilities

$66,989

Stockholders' Equity

-$63,080

Cash & Equivalents

$3,909

← FY 2008 All Quarters FY 2012 →